{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:45Z","timestamp":1792425645084,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["847928"],"award-info":[{"award-number":["847928"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMP21\/00109"],"award-info":[{"award-number":["PMP21\/00109"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0009"],"award-info":[{"award-number":["RD16\/0009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0001"],"award-info":[{"award-number":["RD21\/0005\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RYC2018-024461-I"],"award-info":[{"award-number":["RYC2018-024461-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018412","name":"Sociedad Madrile\u00f1a de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["AC18\/00064"],"award-info":[{"award-number":["AC18\/00064"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["DTS18\/00032"],"award-info":[{"award-number":["DTS18\/00032"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["ERA-PerMed-JTC2018"],"award-info":[{"award-number":["ERA-PerMed-JTC2018"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["ISCIII-RETIC REDinREN RD016\/0009"],"award-info":[{"award-number":["ISCIII-RETIC REDinREN RD016\/0009"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PERSTIGAN AC18\/00071"],"award-info":[{"award-number":["PERSTIGAN AC18\/00071"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI18\/01366"],"award-info":[{"award-number":["PI18\/01366"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI19\/00588"],"award-info":[{"award-number":["PI19\/00588"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI20\/00744"],"award-info":[{"award-number":["PI20\/00744"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI21\/00251"],"award-info":[{"award-number":["PI21\/00251"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI22\/01168"],"award-info":[{"award-number":["PI22\/01168"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.biopha.2022.114197","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:50:02Z","timestamp":1672793402000},"page":"114197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences"],"prefix":"10.1016","volume":"158","author":[{"given":"Raul","family":"Fernandez-Prado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-1812","authenticated-orcid":false,"given":"Priscila","family":"Villalvazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Avello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Gonzalez-de-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Carrasco-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fernandez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Martin-Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Carriazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Sanchez-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vanessa","family":"Perez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.114197_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2215\/CJN.07990520","article-title":"Metabolic acidosis and CKD progression","volume":"16","author":"Madias","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2215\/CJN.11941017","article-title":"Re-Evaluation of the normal range of serum total CO2 concentration","volume":"13","author":"Kraut","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2015.08.028","article-title":"Metabolic acidosis of CKD: an update","volume":"67","author":"Kraut","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/nep.12315","article-title":"Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease","volume":"19","author":"Raphael","year":"2014","journal-title":"Nephrology"},{"key":"10.1016\/j.biopha.2022.114197_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ajkd.2020.10.003","article-title":"Plant-based diets for kidney disease: a guide for clinicians","volume":"77","author":"Joshi","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.ajkd.2014.05.008","article-title":"Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"64","author":"Driver","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib8","doi-asserted-by":"crossref","unstructured":"J.A. Kraut, Disturbances of acid-base balance and bone disease in end-stage renal disease, Semin. Dial., vol. 13, pp. 261\u20136.","DOI":"10.1046\/j.1525-139x.2000.00070.x"},{"key":"10.1016\/j.biopha.2022.114197_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2019.01.036","article-title":"Metabolic acidosis in CKD: core curriculum 2019","volume":"74","author":"Raphael","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0272-6386(95)90179-5","article-title":"Mechanisms causing muscle loss in chronic renal failure","volume":"26","author":"Reaich","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib11","doi-asserted-by":"crossref","unstructured":"P.S. Aronson, G. Giebisch, Effects of pH on potassium: new explanations for old observations, J. Am. Soc. Nephrol. [Internet], J. Am. Soc. Nephrol., vol. 22, 2011 [cited 2022 Nov 12], pp. 1981\u20139. Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/21980112\/\u3009.","DOI":"10.1681\/ASN.2011040414"},{"key":"10.1016\/j.biopha.2022.114197_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2215\/CJN.03730411","article-title":"Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease","volume":"6","author":"Navaneethan","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2022.114197_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2215\/CJN.00010505","article-title":"Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?","volume":"1","author":"Wu","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jcrc.2011.06.001","article-title":"Effects of intracellular acidosis on endothelial function: an overview","volume":"27","author":"Crimi","year":"2012","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.biopha.2022.114197_bib16","doi-asserted-by":"crossref","unstructured":"K. Kalantar-Zadeh, R. Mehrotra, D. Fouque, J.D., Kopple Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure, Semin. Dial., vol. 17, pp. 455\u201365.","DOI":"10.1111\/j.0894-0959.2004.17606.x"},{"key":"10.1016\/j.biopha.2022.114197_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib18","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2010.129","article-title":"Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy","volume":"78","author":"Mahajan","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2009.519","article-title":"Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR","volume":"77","author":"Phisitkul","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib21","doi-asserted-by":"crossref","unstructured":"B. di Iorio, F. Aucella, G. Conte, A. Cupisti, D. Santoro, A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study, J. Nephrol., vol. 25, pp. 437\u201340.","DOI":"10.5301\/jn.5000014"},{"key":"10.1016\/j.biopha.2022.114197_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1745-6215-14-196","article-title":"Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)","volume":"14","author":"Gaggl","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.biopha.2022.114197_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000339329","article-title":"Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review","volume":"35","author":"Susantitaphong","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/TCRM.S344592","article-title":"The effects of oral sodium bicarbonate on renal function and cardiovascular risk in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"17","author":"Cheng","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.biopha.2022.114197_bib25","first-page":"13","article-title":"Nutritional approaches for the management of metabolic acidosis in chronic kidney disease","author":"Noce","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2022.114197_bib26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney disease: improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2022.114197_bib27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5049\/EBP.2021.19.2.29","article-title":"Metabolic acidosis in chronic kidney disease: pathogenesis, clinical consequences, and treatment","volume":"19","author":"Kim","year":"2021","journal-title":"Electrolyte Blood Press."},{"key":"10.1016\/j.biopha.2022.114197_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2019030287","article-title":"A randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the BASE pilot trial","volume":"31","author":"Raphael","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","article-title":"Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension","volume":"394","author":"Wesson","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.114197_bib31","unstructured":"Tricida, Inc. | Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer [Internet]. [cited 2022 Nov 12]. Available from: \u3008https:\/\/ir.tricida.com\/news-releases\/news-release-details\/tricida-reports-topline-results-valor-ckd-phase-3-trial\u3009."},{"key":"10.1016\/j.biopha.2022.114197_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ndt\/gfaa158","article-title":"Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials","volume":"36","author":"Roger","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2022.114197_bib33","unstructured":"\u3008https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/lokelma-epar-public-assessment-report_en.pdf\u3009."},{"key":"10.1016\/j.biopha.2022.114197_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114686","article-title":"Characterization of structure and function of ZS-9, a K+ selective ion trap","volume":"9","author":"Stavros","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.114197_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.653634","article-title":"Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options","volume":"8","author":"Morales","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2022.114197_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.114197_bib38","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.114197_bib39","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ndt\/gfz285","article-title":"Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild\/moderate versus severe\/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study","volume":"36","author":"Roger","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2022.114197_bib41","unstructured":"\u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/207078s003lbl.pdf\u3009."},{"key":"10.1016\/j.biopha.2022.114197_bib42","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/ckj\/sfaa237","article-title":"Effects of sodium zirconium cyclosilicate on sodium and potassium excretion in healthy adults: a phase 1 study","volume":"14","author":"N\u00e5g\u00e5rd","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.biopha.2022.114197_bib43","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2019050450","article-title":"A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia","volume":"30","author":"Fishbane","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib44","first-page":"54","article-title":"Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-global study","volume":"7","author":"Zannad","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.biopha.2022.114197_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.physiol.69.040705.142215","article-title":"Molecular mechanisms of renal ammonia transport","volume":"69","author":"Weiner","year":"2007","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2022.114197_bib46","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ndt\/gfaa241","article-title":"Sodium zirconium cyclosilicate for hyperkalemia: a collateral acid-base benefit?","volume":"36","author":"Wesson","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.biopha.2022.114197_bib47","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2215\/CJN.10391012","article-title":"Proximal tubule function and response to acidosis","volume":"9","author":"Curthoys","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1681\/ASN.2008020166","article-title":"Mechanisms in hyperkalemic renal tubular acidosis","volume":"20","author":"Karet","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib49","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2017111163","article-title":"Mechanism of hyperkalemia-induced metabolic acidosis","volume":"29","author":"Harris","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib50","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.08580813","article-title":"Regulation of potassium homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120965838","article-title":"Polysulfonate resins in hyperkalemia: a systematic review","volume":"7","author":"Wong","year":"2020","journal-title":"Can. J. Kidney Health Dis."},{"key":"10.1016\/j.biopha.2022.114197_bib52","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0016-5085(69)80090-9","article-title":"Alkalosis resulting from combined administration of a \u201cnonsystemic\u201d antacid and a cation-exchange resin","volume":"56","author":"Schroeder","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.114197_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJM197602122940703","article-title":"Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism","volume":"294","author":"Szylman","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.114197_bib54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5414\/CN110688","article-title":"The effect of sodium zirconium cyclosilicate on acid-base balance in chronic kidney disease","volume":"97","author":"Mori","year":"2022","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.114197_bib56","unstructured":"CHMP, Committee for Medicinal Products for Human Use (CHMP) Assessment report Veltassa, 2017 [cited 2022 Jul 17]; Available from: \u3008www.ema.europa.eu\/contact\u3009."},{"key":"10.1016\/j.biopha.2022.114197_bib57","unstructured":"A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia \u2013 Full Text View \u2013 ClinicalTrials.gov [Internet]. [cited 2022 Jul 17]. Available from: \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05056727\u3009."},{"key":"10.1016\/j.biopha.2022.114197_bib58","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ki.2015.78","article-title":"Urea and protein carbamylation in ESRD: surrogate markers or partners in crime?","volume":"87","author":"Velasquez","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib59","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1073\/pnas.1517096113","article-title":"Protein carbamylation is a hallmark of aging","volume":"113","author":"Gorisse","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.114197_bib60","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.kint.2021.10.018","article-title":"Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease","volume":"101","author":"Jankowski","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib61","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/ki.2014.429","article-title":"Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease","volume":"87","author":"Drechsler","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib62","doi-asserted-by":"crossref","unstructured":"A.H. Berg, C. Drechsler, J. Wenger, R. Buccafusca, T. Hod, S. Kalim, et al., Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure, Sci. Transl. Med. [Internet]. Sci. Transl. Med., vol. 5, 2013 [cited 2022 Nov 12], pp. 1\u201311. Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/23467560\/\u3009.","DOI":"10.1126\/scitranslmed.3005218"},{"key":"10.1016\/j.biopha.2022.114197_bib63","doi-asserted-by":"crossref","unstructured":"S. Kalim, A.H. Berg, S.A. Karumanchi, R. Thadhani, A.S. Allegretti, S. Nigwekar, et al., Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study. Nephrol. Dial. Transplant. [Internet]. Nephrol. Dial. Transplant., vol. 37, 2021 [cited 2022 Nov 12], pp. 139\u201347. Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/33661286\/\u3009.","DOI":"10.1093\/ndt\/gfaa347"},{"key":"10.1016\/j.biopha.2022.114197_bib64","first-page":"1","article-title":"Effect of sodium zirconium cyclosilicate on serum potassium and bicarbonate in patients with hyperkalemia and metabolic acidosis associated with chronic kidney disease: rationale and design of the NEUTRALIZE study","author":"Ash","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2022.114197_bib65","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.kint.2018.11.033","article-title":"Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis","volume":"95","author":"Goraya","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.114197_bib66","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1681\/ASN.2017121268","article-title":"Acid stimulation of the citrate transporter NaDC-1 requires Pyk2 and ERK1\/2 signaling pathways","volume":"29","author":"Zacchia","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114197_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.21037\/atm.2018.07.37","article-title":"Acidosis and citrate: provocative interactions","volume":"6","author":"Hering-Smith","year":"2018","journal-title":"Ann. Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222015864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222015864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:37:16Z","timestamp":1779795436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222015864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":67,"alternative-id":["S0753332222015864"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114197","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114197"}}